donor-derived cd34+ hsc with crispr/cas9-mediated cd33 deletion
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2023 (NCT05662904)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05662904 | Phase 1 | Dec 31, 2023 | German Cancer Research Center, Technical University of Dresden, University of Heidelberg |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| German Cancer Research Center | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Technical University of Dresden | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Heidelberg | Academic/Hospital | 1 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1